LER occurs when a known amount of endotoxin is added to a drug product but cannot be recovered or detected during testing over time. This is not a failure of the test itself, but rather a where the endotoxin molecules (LPS) are rearranged into structures that the Limulus Amebocyte Lysate (LAL) reagent cannot recognize. Common LER Triggers
Citrate, phosphate, and EDTA often accelerate masking. pda technical report 82 pdf
PDA Technical Report No. 82 (TR 82) is a critical industry document titled . Published by the Parenteral Drug Association, it provides a comprehensive framework for understanding, investigating, and managing the masked endotoxin phenomenon in biopharmaceutical formulations. ⚡ Quick Summary of TR 82 LER occurs when a known amount of endotoxin
Use "Natural Endotoxin" (NOE) vs. "Control Standard Endotoxin" (CSE) based on the report’s recommendations. PDA Technical Report No
If LER is found, develop a robust demasking protocol that can be consistently replicated in QC.